Cite

HARVARD Citation

    Barth, P. et al. (2021). Outcomes of lenalidomide‐ or bortezomib‐based regimens in older patients with plasma cell myeloma. American journal of hematology. 96 (1), pp. 14-22. [Online]. 
  
Back to record